As part of RHU TIPITCH – Transforming the Prognosis of Haemorrhagic Stroke, we are committed to improving the management of haemorrhagic strokes by exploring new therapeutic approaches.

At the International Stroke Conference 2025 #ISC2025, experts shared major advances in the treatment of deep intracerebral haemorrhage—an issue at the very heart of our project.

🔹 Minimally invasive surgery: what progress is being made?
– MISTIE and MIPS, two innovative techniques for haematoma evacuation, show promising results but still require further study to demonstrate a clear functional benefit.
– Decompressive surgery, assessed in the SWITCH trial, remains a debated option with no confirmed improvement in six‑month recovery outcomes.

🔹 What levers for better medical management?
Professor Charlotte Cordonnier, lead investigator of TIPITCH, emphasised the importance of combined strategies to limit haematoma expansion, reduce cerebral oedema, and promote clot resolution. New avenues are emerging, particularly around modulation of the inflammatory response.

These advances strongly align with our mission: improving the treatment of haemorrhagic stroke and optimising care pathways.

📌 The key challenge for upcoming studies?
Identifying the patients most likely to benefit from these combined approaches and refining evaluation criteria.

👉 We will continue to share major developments on this topic.